Maan Aluminium Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 11:03 pm

Quick Insight

Maan Aluminium Ltd's current share price of 114 reflects a P/E ratio of 41.9, indicating investors are willing to pay a premium for future earnings. With a ROE of 9.08% and ROCE of 10.7%, the company's profitability and capital efficiency are decent but not exceptional. The low OPM of 3.13% suggests room for improvement in operational efficiency. The company's high P/BV ratio of 4.55x may indicate overvaluation compared to its book value. Despite this, Maan Aluminium's healthy ICR of 14.21x and strong reserves of 151 Cr provide a cushion against its borrowings of ₹90Cr. Shareholders, especially promoters who hold 58.87%, seem confident in the company's prospects, but attracting more institutional investment could enhance market confidence and liquidity.

Competitors of Maan Aluminium Ltd

All Competitor Stocks of Maan Aluminium Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:35 am

Below is a detailed analysis of the quarterly data for Maan Aluminium Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 211.19 Cr.. The value appears to be declining and may need further review. It has decreased from 245.86 Cr. (Mar 2025) to 211.19 Cr., marking a decrease of 34.67 Cr..
• For Expenses, as of Jun 2025, the value is 206.25 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 238.16 Cr. (Mar 2025) to 206.25 Cr., marking a decrease of 31.91 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.94 Cr.. The value appears to be declining and may need further review. It has decreased from 7.70 Cr. (Mar 2025) to 4.94 Cr., marking a decrease of 2.76 Cr..
• For OPM %, as of Jun 2025, the value is 2.34%. The value appears to be declining and may need further review. It has decreased from 3.13% (Mar 2025) to 2.34%, marking a decrease of 0.79%.
• For Other Income, as of Jun 2025, the value is 1.99 Cr.. The value appears strong and on an upward trend. It has increased from 1.37 Cr. (Mar 2025) to 1.99 Cr., marking an increase of 0.62 Cr..
• For Interest, as of Jun 2025, the value is 1.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.13 Cr. (Mar 2025) to 1.45 Cr., marking an increase of 0.32 Cr..
• For Depreciation, as of Jun 2025, the value is 1.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.72 Cr. (Mar 2025) to 1.82 Cr., marking an increase of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.66 Cr.. The value appears to be declining and may need further review. It has decreased from 6.22 Cr. (Mar 2025) to 3.66 Cr., marking a decrease of 2.56 Cr..
• For Tax %, as of Jun 2025, the value is 25.41%. The value appears to be improving (decreasing) as expected. It has decreased from 36.66% (Mar 2025) to 25.41%, marking a decrease of 11.25%.
• For Net Profit, as of Jun 2025, the value is 2.73 Cr.. The value appears to be declining and may need further review. It has decreased from 3.94 Cr. (Mar 2025) to 2.73 Cr., marking a decrease of 1.21 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.50. The value appears to be declining and may need further review. It has decreased from 0.73 (Mar 2025) to 0.50, marking a decrease of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:46 am

Below is a detailed analysis of the balance sheet data for Maan Aluminium Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
• For Reserves, as of Mar 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 136.00 Cr. (Mar 2024) to 151.00 Cr., marking an increase of 15.00 Cr..
• For Borrowings, as of Mar 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 33.00 Cr. (Mar 2024) to 90.00 Cr., marking an increase of 57.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 300.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 225.00 Cr. (Mar 2024) to 300.00 Cr., marking an increase of 75.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 52.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 188.00 Cr.. The value appears strong and on an upward trend. It has increased from 165.00 Cr. (Mar 2024) to 188.00 Cr., marking an increase of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 300.00 Cr.. The value appears strong and on an upward trend. It has increased from 225.00 Cr. (Mar 2024) to 300.00 Cr., marking an increase of 75.00 Cr..

Notably, the Reserves (151.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Maan Aluminium Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. It has decreased from 10.00 (Mar 23) to 5.00, marking a decrease of 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 6.06. This value is within the healthy range. It has decreased from 36.96 (Mar 23) to 6.06, marking a decrease of 30.90.
• For Diluted EPS (Rs.), as of Mar 24, the value is 6.06. This value is within the healthy range. It has decreased from 36.96 (Mar 23) to 6.06, marking a decrease of 30.90.
• For Cash EPS (Rs.), as of Mar 24, the value is 6.92. This value is within the healthy range. It has decreased from 40.26 (Mar 23) to 6.92, marking a decrease of 33.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 30.15. It has decreased from 96.35 (Mar 23) to 30.15, marking a decrease of 66.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 30.15. It has decreased from 96.35 (Mar 23) to 30.15, marking a decrease of 66.20.
• For Dividend / Share (Rs.), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 3.00 (Mar 23) to 0.00, marking a decrease of 3.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 176.21. It has decreased from 601.91 (Mar 23) to 176.21, marking a decrease of 425.70.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 9.68. This value is within the healthy range. It has decreased from 56.54 (Mar 23) to 9.68, marking a decrease of 46.86.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.81. This value is within the healthy range. It has decreased from 53.23 (Mar 23) to 8.81, marking a decrease of 44.42.
• For PBT / Share (Rs.), as of Mar 24, the value is 8.13. This value is within the healthy range. It has decreased from 49.58 (Mar 23) to 8.13, marking a decrease of 41.45.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 6.05. This value is within the healthy range. It has decreased from 36.96 (Mar 23) to 6.05, marking a decrease of 30.91.
• For PBDIT Margin (%), as of Mar 24, the value is 5.49. This value is below the healthy minimum of 10. It has decreased from 9.39 (Mar 23) to 5.49, marking a decrease of 3.90.
• For PBIT Margin (%), as of Mar 24, the value is 5.00. This value is below the healthy minimum of 10. It has decreased from 8.84 (Mar 23) to 5.00, marking a decrease of 3.84.
• For PBT Margin (%), as of Mar 24, the value is 4.61. This value is below the healthy minimum of 10. It has decreased from 8.23 (Mar 23) to 4.61, marking a decrease of 3.62.
• For Net Profit Margin (%), as of Mar 24, the value is 3.43. This value is below the healthy minimum of 5. It has decreased from 6.14 (Mar 23) to 3.43, marking a decrease of 2.71.
• For Return on Networth / Equity (%), as of Mar 24, the value is 20.08. This value is within the healthy range. It has decreased from 38.35 (Mar 23) to 20.08, marking a decrease of 18.27.
• For Return on Capital Employeed (%), as of Mar 24, the value is 28.54. This value is within the healthy range. It has decreased from 53.32 (Mar 23) to 28.54, marking a decrease of 24.78.
• For Return On Assets (%), as of Mar 24, the value is 14.54. This value is within the healthy range. It has decreased from 22.22 (Mar 23) to 14.54, marking a decrease of 7.68.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.19. This value is within the healthy range. It has decreased from 0.42 (Mar 23) to 0.19, marking a decrease of 0.23.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 4.24. It has increased from 4.11 (Mar 23) to 4.24, marking an increase of 0.13.
• For Current Ratio (X), as of Mar 24, the value is 2.55. This value is within the healthy range. It has increased from 1.90 (Mar 23) to 2.55, marking an increase of 0.65.
• For Quick Ratio (X), as of Mar 24, the value is 1.87. This value is within the healthy range. It has increased from 1.52 (Mar 23) to 1.87, marking an increase of 0.35.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.98. This value is within the healthy range. It has decreased from 6.06 (Mar 23) to 4.98, marking a decrease of 1.08.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.11 (Mar 23) to 0.00, marking a decrease of 8.11.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.45 (Mar 23) to 0.00, marking a decrease of 7.45.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.89 (Mar 23) to 0.00, marking a decrease of 91.89.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.55 (Mar 23) to 0.00, marking a decrease of 92.55.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 14.21. This value is within the healthy range. It has decreased from 15.45 (Mar 23) to 14.21, marking a decrease of 1.24.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.89. This value is within the healthy range. It has decreased from 11.10 (Mar 23) to 9.89, marking a decrease of 1.21.
• For Enterprise Value (Cr.), as of Mar 24, the value is 773.29. It has increased from 287.28 (Mar 23) to 773.29, marking an increase of 486.01.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 23) to 0.81, marking an increase of 0.46.
• For EV / EBITDA (X), as of Mar 24, the value is 14.78. This value is within the healthy range. It has increased from 3.76 (Mar 23) to 14.78, marking an increase of 11.02.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 23) to 0.77, marking an increase of 0.49.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.88 (Mar 23) to 0.00, marking a decrease of 91.88.
• For Price / BV (X), as of Mar 24, the value is 4.55. This value exceeds the healthy maximum of 3. It has increased from 1.80 (Mar 23) to 4.55, marking an increase of 2.75.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 23) to 0.77, marking an increase of 0.49.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.21 (Mar 23) to 0.04, marking a decrease of 0.17.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness